Imagion Financial Statements From 2010 to 2024
| IBXXF Stock | USD 0.04 0.00 0.00% |
Check Imagion Biosystems financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Imagion Biosystems' main balance sheet or income statement drivers, such as , as well as many indicators such as . Imagion financial statements analysis is a perfect complement when working with Imagion Biosystems Valuation or Volatility modules.
Imagion |
Imagion Biosystems Limited Company Operating Margin Analysis
Imagion Biosystems' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Imagion Biosystems Operating Margin | (30.08) % |
Most of Imagion Biosystems' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Imagion Biosystems Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Imagion Biosystems Limited has an Operating Margin of -30.0828%. This is 14.25% lower than that of the Healthcare sector and 52.52% lower than that of the Diagnostics & Research industry. The operating margin for all United States stocks is notably higher than that of the company.
Imagion Biosystems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Imagion Biosystems's current stock value. Our valuation model uses many indicators to compare Imagion Biosystems value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Imagion Biosystems competition to find correlations between indicators driving Imagion Biosystems's intrinsic value. More Info.Imagion Biosystems Limited is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Imagion Biosystems' earnings, one of the primary drivers of an investment's value.About Imagion Biosystems Financial Statements
Imagion Biosystems stakeholders use historical fundamental indicators, such as Imagion Biosystems' revenue or net income, to determine how well the company is positioned to perform in the future. Although Imagion Biosystems investors may analyze each financial statement separately, they are all interrelated. For example, changes in Imagion Biosystems' assets and liabilities are reflected in the revenues and expenses on Imagion Biosystems' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Imagion Biosystems Limited. Please read more on our technical analysis and fundamental analysis pages.
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. The company was incorporated in 2016 and is based in San Diego, California. Imagion Biosystems operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Imagion Pink Sheet
Imagion Biosystems financial ratios help investors to determine whether Imagion Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Imagion with respect to the benefits of owning Imagion Biosystems security.